Navigation Links
Omeros to Present at Jefferies 2012 Global Healthcare Conference
Date:5/29/2012

SEATTLE, May 29, 2012 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER), a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, is scheduled to present at the Jefferies 2012 Global Healthcare Conference next week.  The presentation is scheduled for 4:30 p.m. Eastern Time on Monday, June 4, 2012.

The presentation will be webcast. The live and archived webcasts can be accessed on the "Events" page of the Company's website at www.omeros.com.  

About Omeros Corporation
Omeros is a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system. The Company's most clinically advanced product candidates are derived from its proprietary PharmacoSurgery™ platform designed to improve clinical outcomes of patients undergoing a wide range of surgical and medical procedures. Omeros has four ongoing clinical development programs. Omeros may also have the near-term capability, through its GPCR program, to add a large number of new drug targets and their corresponding compounds to the market. Behind its clinical candidates and GPCR platform, Omeros is building a diverse pipeline of protein and small-molecule preclinical programs targeting inflammation, coagulopathies and central nervous system disorders.


'/>"/>
SOURCE Omeros Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Omeros Announces Initiation of Patient Enrollment in OMS201 Phase 1 Study
2. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
3. Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302
4. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
5. Omeros Receives $3.1 Million Milestone Payment from The Stanley Medical Research Institute for Schizophrenia Program
6. Omeros Prices Initial Public Offering of Common Stock at $10.00 Per Share
7. Omeros Announces National Institute on Drug Abuses Support for Phase 2 Clinical Study in Addiction Program
8. Omeros Corporation to Host Third Quarter 2009 Financial Results Conference Call on November 19
9. Daniel K. Spiegelman Elected to Board of Directors of Omeros
10. Omeros Reports Additional Phase 2 Data Showing Multiple Clinical Benefits In Patients Undergoing Meniscectomy Surgery
11. Omeros Selects Clinical Candidate for MASP-2 Program With Potential Applicability to Multiple Inflammatory Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... , July 4, 2015 A ... of hypertension, diabetes and thyroid disorders in Central and ... educational platforms and a major conference dedicated to these ... Manage Diabetes Online , Manage Hypertension Online ... developed and operated by EXCEMED - combine ...
(Date:7/3/2015)... 3, 2015 Un fournisseur ... que sont l,hypertension, le diabète et les troubles ... éducatives gratuites et d,une conférence majeure dédiée à ... ) , Les formations ... Prendre en charge l,hypertension en ligne ...
(Date:7/3/2015)... MUMBAI , July 3, 2015 /PRNewswire/ ... gab heute bekannt, vorbehaltlich bestimmter Abschlussbedingungen eine ... Russland erworben zu haben. Mit dieser Übernahme ... der mit einem Umsatz von 765 Mrd. ... größten Pharmamärkten der Welt gehörte (IMS Health). ...
Breaking Medicine Technology:Combating Three Major Chronic Diseases in Central and South-East Asia With Medical Education 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Lupin übernimmt Biocom aus Russland 2Lupin übernimmt Biocom aus Russland 3
... 2a Clinical Trial at UCSD, NOVATO, ... or the "Company") (OTC Bulletin Board:,RPTP), today ... (the,"Agreement") with the University of California, San ... trial to evaluate a delayed-release preparation,of cysteamine ...
... Corporation, a,Georgia-based biotech company, announced today a ... collaboration with Cato Research Ltd.,its global contract ... will help support continued development of Abeome,s ... vastly improves the development of,monoclonal antibodies and ...
Cached Medicine Technology:Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 2Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 3Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 4Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease 5Abeome and Cato Research to Collaborate on Ovarian Cancer Therapeutic 2
(Date:7/6/2015)... ... , ... “ TapGlance ” was featured on NewsWatch as part of its ... market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and technology ... helps users visualize what rooms will look like before they even start renovating.. , ...
(Date:7/6/2015)... ... , ... June 22, 2015, Fox News in a report titled “ Female Hair Loss Needs to ... a quarter of all women in the U.S. will suffer from thinning hair or hair ... discussed. One woman, a former beauty queen, who was interviewed for the report began losing ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... ... care from nurses or midwives, yet there is a large gap between the ... midwifery research required to improve health outcomes and reduce unnecessary or ineffective treatments ...
(Date:7/6/2015)... ... ... Olive Fertility Centre is proud to announce that Olive medical director Dr. ... the department of Family Practice. , “This award is a real honour,” says Dr ... is changing so rapidly and we are also developing new models of patient-centred care ...
(Date:7/6/2015)... ... July 06, 2015 , ... Longevity, the highest ... with Woodbridge Walk-In Urgent Care to offer on-site health screenings. These ultrasound screenings ... Screenings are affordable and accurate and run about an hour long with same ...
Breaking Medicine News(10 mins):Health News:Create a Space with TapGlance, a Revolutionary Interior Design Application 2Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:Columbia Nursing Nairobi Summit: Setting a Clinical Research Agenda for Africa 2Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Woodbridge Walk-In Offers Affordable Early Detection Health Screenings Through Longevity 2
... ... of postmortem procedures , ... AZ (Vocus) February 4, 2010 -- Doctors or pathology technicians perform autopsies to diagnose any ... to the decedent’s death. The postmortem examination is of great importance to the family of ...
... ... risks associated with use of popular GlaxoSmithKline diabetes drug , ... Mineola, NY (Lexis Nexis) February 4, 2010 ... of opinions concerning the safety of its much touted diabetes drug Avandia , ...
... This ... expertise in the field of Lower Gastrointestinal, Urological and Sexual Dysfunction disorders. , ... (PRWEB) February 4, 2010 -- In an ... field of Lower Gastrointestinal, Urological and Sexual Dysfunction disorders with colleagues and patients around the ...
... (February 4, 2010) In a study to be presented today ... Meeting , in Chicago, researchers will unveil findings that detail an ... near-term scheduled births that did not have an appropriate medical ... by induction of labor, has been on the rise in recent ...
... COPD MAY BE OVERSTATED , Inhaled ... obstructive pulmonary disease (COPD). However, new research suggests that ICS ... patients with COPD. Researchers from India conducted a metaanalysis of ... versus placebo in prevention of COPD exacerbations. The use of ...
... CHICAGO, Ill. (February 4, 2010) In a study to ... annual meeting, The Pregnancy Meeting , in Chicago, researchers will ... treatment for depression during pregnancy. "Depression during pregnancy is ... both the mother and the baby as well as the ...
Cached Medicine News:Health News:Author Presents a Practical Guide for Postmortem Examinations 2Health News:New Scientific Studies Show Further Evidence of Avandia Dangers 2Health News:New Scientific Studies Show Further Evidence of Avandia Dangers 3Health News:International Pelvic Floor Muscle Expert Presents Live Webinars on Telemedecine 2Health News:International Pelvic Floor Muscle Expert Presents Live Webinars on Telemedecine 3Health News:Report documents statewide initiative to reduce near-term scheduled births 2Health News:News briefs from the February issue of Chest 2Health News:Acupuncture found effective against depression during pregnancy 2
Microseal 'F' foil, seals plates for cold storage (or cycling >25l), disposable, pkg of 100...
... Applied Biosystems has developed a comprehensive ... when using sequence detection systems (SDS) ... simple and easy to follow. Many ... concentration and the thermal cycling protocol ...
Microporous tape sheets for covering 96-well plates, square-well or flat-bottom blocks.;...
ThermalSeal RT (2mil) is Optically Clear for Real Time PCR and easy to apply. Works for all plates....
Medicine Products: